C-reactive Protein, Lung Hyperinflation and Heart Rate Variability in Chronic Obstructive Pulmonary Disease –A Pilot Study

References

• Sin DD, Man SFP. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2005; 2:8–11.
   PubMedGoogle Scholar
• Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 1996; 348:567–72.
   PubMed Web of Science ®Google Scholar
• Engström G, Wollmer P, Hedblad B, Juul-Möller S, Valind S, Janzon L. Occurrence and prognostic significance of ventricular arrhythmia is related to pulmonary function: a study from “men born in 1914”, Malmö, Sweden. Circulation 2001; 103: 3086–91.
   Google Scholar
• Anthonisen NR, Connett JE, Enright PL, Manfreda J. Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002; 166: 333–9.
   PubMed Web of Science ®Google Scholar
• Ferguson GT, Calverley PMA, Anderson JA, Incidence of cardiac events in COPD patients in the TORCH study. Am J Respir Crit Care Med 2008; 177:A962.
   Google Scholar
• Vestbo J. Torch Study Group. The TORCH (towards a revolution in COPD health) survival study protocol. Eur Respir J 2004; 24:206e10.
   Google Scholar
• McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA; TORCH Clinical Endpoint Committee. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 2007; 62(5):411–5.
   PubMed Web of Science ®Google Scholar
• Casanova C, Cote C, de Torres JP Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171(6):591–7.
   PubMed Web of Science ®Google Scholar
• Zaman M, Mahmood S, Altayeh A. Low inspiratory capacity to total lung capacity ratio is a risk factor for chronic obstructive pulmonary disease exacerbation. Am J Med Sci 2010; 339(5):411–4.
   PubMed Web of Science ®Google Scholar
• Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175(3):250–5.
   PubMed Web of Science ®Google Scholar
• Sin DD, Man SF. Systemic inflammation and mortality in chronic obstructive pulmonary disease. Can J Physiol Pharmacol 2007; 85(1):141–7.
   PubMed Web of Science ®Google Scholar
• Casolo G, Balli E, Taddei T, Amuhasi J, Gori C. Decreased spontaneous heart rate variability in congestive heart failure. Am J Cardiol 1989; 64:1162–7.
   PubMed Web of Science ®Google Scholar
• Kleiger RE, Stein PK, Bigger JT. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol 2005; 10(1):88–101.
   PubMed Web of Science ®Google Scholar
• Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996; 17(3):354–81.
   PubMed Web of Science ®Google Scholar
• Volterrani M, Scalvini S, Mazzuero G, Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest 1994; 106(5):1432–7.
   PubMed Web of Science ®Google Scholar
• Stein PK, Nelson P, Rottman JN, Heart rate variability reflects severity of COPD in PiZ alpha1-antitrypsin deficiency. Chest 1998; 113(2):327–33.
   PubMed Web of Science ®Google Scholar
• Takabatake N, Nakamura H, Minamihaba O, A novel pathophysiologic phenomenon in cachexic patients with chronic obstructive pulmonary disease: the relationship between the circadian rhythm of circulating leptin and the very low-frequency component of heart rate variability. Am J Respir Crit Care Med 2001; 163(6):1314–9.
   PubMed Web of Science ®Google Scholar
• Bartels MN, Jelic S, Ngai P, Basner RC, DeMeersman RE. High-frequency modulation of heart rate variability during exercise in patients with COPD. Chest 2003; 124(3):863–9.
   PubMed Web of Science ®Google Scholar
• Miller MR, Crapo R, Hankinson J, ATS/ERS Task Force. General considerations for lung function testing. Eur Respir J 2005; 26(1):153–61.
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005; 526(2):319–38.
   Google Scholar
• Wanger J, Clausen JL, Coates A, Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26(3):511–22.
   PubMed Web of Science ®Google Scholar
• Macintyre N, Crapo RO, Viegi G, Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26(4):720–35.
   PubMed Web of Science ®Google Scholar
• Camillo CA, Pitta F, Possani HV, Heart rate variability and disease characteristics in patients with COPD. Lung 2008; 186(6):393–401.
   PubMed Web of Science ®Google Scholar
• Antonelli Incalzi R, Corsonello A, Trojano L, Heart rate variability and drawing impairment in hypoxemic COPD. Brain Cogn 2009; 70(1):163–70.
   PubMed Web of Science ®Google Scholar
• Borovikova LV, Ivanova S, Zhang M, Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405:458–62.
   PubMed Web of Science ®Google Scholar
• März P, Cheng JG, Gadient RA, Sympathetic neurons can produce and respond to interleukin 6. Proc Natl Acad Sci USA 1998; 95:3251–6.
   PubMed Web of Science ®Google Scholar
• Banks WA, Kastin AJ. Blood to brain transport of interleukin links the immune and central nervous systems. Life Sci 1991; 48:PL117–21.
   PubMed Web of Science ®Google Scholar
• Undem BJ, Kollarik M. The role of vagal afferent nerves in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2(4):355–360; discussion371–2.
   PubMedGoogle Scholar
• Lanza GA, Sgueglia GA, Cianflone D, , SPAI (Stratificazione Prognostica dell'Angina Instabile) Investigators. Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris. Am J Cardiol Jun 2006; 15;97(12):1702–6.
   Google Scholar
• Aronson D, Mittleman MA, Burger AJ. Interleukin-6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure. J Cardiovasc Electrophysiol 2001; 12:294–300.
   PubMed Web of Science ®Google Scholar
• Lampert R, Bremner JD, Su S, Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. Am Heart J 2008; 156(4):759. e1–759.e7.
   PubMed Web of Science ®Google Scholar
• Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Hansen JF. C-reactive protein, heart rate variability and prognosis in community subjects with no apparent heart disease. J Intern Med 2006; 260(4):377–87.
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Foster G, Curtis JL, , NETT Research Group. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173(12):1326–34.
   PubMed Web of Science ®Google Scholar
• Watz H, Waschki B, Meyer T, Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest 2010; 138(1):32–8.
   PubMed Web of Science ®Google Scholar
• Porszasz J, Emtner M, Goto S, Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest 2005; 128(4):2025–34.
   PubMed Web of Science ®Google Scholar
• Camillo CA, Laburu Vde M, Gonçalves NS, Improvement of heart rate variability after exercise training and its predictors in COPD. Respir Med 2011; 105(7):1054–62.
   PubMed Web of Science ®Google Scholar